ID

45159

Beschrijving

Principal Investigator: Christopher Haiman, ScD, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA MeSH: Prostatic Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000306 Multiple GWA studies of prostate cancer conducted in European White populations are ongoing. These studies will continue to have a dramatic impact on our understanding of the contribution of common genetic variation on inter-individual susceptibility to this common cancer. Important questions that will remain unanswered, however, are whether all common risk alleles for prostate cancer will be revealed in studies limited to populations of European ancestry. A comprehensive examination of common genetic variation in men of Japanese, Latino, and African ancestry will be required to understand population differences in disease risk and to reveal the full spectrum of causal alleles that exist in these populations. Further, genetic and environmental diversity is likely to contribute to ethnic heterogeneity of genetic effects. Elucidating gene x gene and gene x environment interactions is also likely to provide knowledge that may be critical for understanding the contribution of genetic susceptibility to racial/ethnic disparities in prostate cancer incidence and for translating the findings from GWA studies into interventions. In this study we plan to undertake a genome-wide association study (GWAS) of prostate cancer in the Multiethnic Cohort (MEC) Study. We propose the following hypotheses: (a) that inherited DNA variation influences risk of prostate cancer; (b) that many of the causal alleles will be outside known "candidate genes" requiring an agnostic, comprehensive search; and (c) that performing this search in a multi-ethnic cohort is more powerful than a study limited to a single population to reveal the full range of causal alleles relevant to the U.S. population. The version 1 release of this dataset will include genotype data for the Japanese and Latino populations in the study. The version 2 release will include data for the African ancestry population along with the Japanese and Latino subjects. The version 3 release will include fully-cleaned genotype data for all three populations. This study is part of the Gene Environment Association Studies initiative (GENEVA, http://www.genevastudy.org) funded by the trans-NIH Genes, Environment, and Health Initiative (GEI). The overarching goal is to identify novel genetic factors that contribute to prostate cancer through large-scale genome-wide association studies of a well-characterized multi-ethnic cohort. Genotyping was performed at the Broad Institute of MIT and Harvard, a GENEVA genotyping center and at the University of Southern California. Data cleaning and harmonization were performed at the GEI-funded GENEVA Coordinating Center at the University of Washington. As an add-on to this GWAS we performed a targeted re-sequencing of all known prostate cancer risk loci in the samples from the MEC. Sequencing was performed in Dr. Reich's lab at Harvard Medical School.

Link

dbGaP study = phs000306

Trefwoorden

  1. 30-08-22 30-08-22 - Simon Heim
  2. 12-10-22 12-10-22 - Adrian Schulz
Houder van rechten

Christopher Haiman, ScD, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA

Geüploaded op

12 oktober 2022

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

dbGaP phs000306 A Multiethnic GWAS of Prostate Cancer

Eligibility Criteria

Inclusion and exclusion criteria
Beschrijving

Inclusion and exclusion criteria

Prostate cancer cases have an invasive prostate cancer diagnosis after (incident) entry into cohort
Beschrijving

Prostate cancer cases have an invasive prostate cancer diagnosis after (incident) entry into cohort

Datatype

boolean

Alias
UMLS CUI [1,1]
C1706256
UMLS CUI [1,2]
C0600139
UMLS CUI [1,3]
C0011900
UMLS CUI [1,4]
C0231290
UMLS CUI [1,5]
C1512693
UMLS CUI [1,6]
C0599755
Controls were matched to cases on race/ethnicity, area of residence (California or Hawaii) and age at entry into cohort. Subjects were excluded from control selection if a prevalent (before entry to cohort) diagnosis of prostate cancer was reported on the baseline questionnaire or from the tumor registry.
Beschrijving

Controls were matched to cases on race/ethnicity, area of residence (California or Hawaii) and age at entry into cohort. Subjects were excluded from control selection if a prevalent (before entry to cohort) diagnosis of prostate cancer was reported on the baseline questionnaire or from the tumor registry.

Datatype

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0150103
UMLS CUI [1,3]
C0009932
UMLS CUI [1,4]
C1706256
UMLS CUI [1,5]
C3853635
UMLS CUI [1,6]
C0237096
UMLS CUI [1,7]
C0001779
UMLS CUI [2,1]
C0680251
UMLS CUI [2,2]
C0009932
UMLS CUI [2,3]
C0011900
UMLS CUI [2,4]
C0600139
UMLS CUI [2,5]
C0332152
UMLS CUI [2,6]
C1512693
UMLS CUI [2,7]
C0599755
UMLS CUI [2,8]
C0034394
UMLS CUI [2,9]
C0805443

Similar models

Eligibility Criteria

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Inclusion and exclusion criteria
Prostate cancer cases have an invasive prostate cancer diagnosis after (incident) entry into cohort
Item
Prostate cancer cases have an invasive prostate cancer diagnosis after (incident) entry into cohort
boolean
C1706256 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C0231290 (UMLS CUI [1,4])
C1512693 (UMLS CUI [1,5])
C0599755 (UMLS CUI [1,6])
Controls were matched to cases on race/ethnicity, area of residence (California or Hawaii) and age at entry into cohort. Subjects were excluded from control selection if a prevalent (before entry to cohort) diagnosis of prostate cancer was reported on the baseline questionnaire or from the tumor registry.
Item
Controls were matched to cases on race/ethnicity, area of residence (California or Hawaii) and age at entry into cohort. Subjects were excluded from control selection if a prevalent (before entry to cohort) diagnosis of prostate cancer was reported on the baseline questionnaire or from the tumor registry.
boolean
C1512693 (UMLS CUI [1,1])
C0150103 (UMLS CUI [1,2])
C0009932 (UMLS CUI [1,3])
C1706256 (UMLS CUI [1,4])
C3853635 (UMLS CUI [1,5])
C0237096 (UMLS CUI [1,6])
C0001779 (UMLS CUI [1,7])
C0680251 (UMLS CUI [2,1])
C0009932 (UMLS CUI [2,2])
C0011900 (UMLS CUI [2,3])
C0600139 (UMLS CUI [2,4])
C0332152 (UMLS CUI [2,5])
C1512693 (UMLS CUI [2,6])
C0599755 (UMLS CUI [2,7])
C0034394 (UMLS CUI [2,8])
C0805443 (UMLS CUI [2,9])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial